IE890087L - Recombinant human interleukin-1 alpha polypeptides - Google Patents
Recombinant human interleukin-1 alpha polypeptidesInfo
- Publication number
- IE890087L IE890087L IE890087A IE8789A IE890087L IE 890087 L IE890087 L IE 890087L IE 890087 A IE890087 A IE 890087A IE 8789 A IE8789 A IE 8789A IE 890087 L IE890087 L IE 890087L
- Authority
- IE
- Ireland
- Prior art keywords
- polypeptides
- human interleukin
- recombinant human
- contain
- alpha polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to homogeneous recombinant human interleukin- 1 alpha polypeptides, to DNA sequences which code for such polypeptides, to recombinant vectors which contain a DNA of this type, to host organisms which contain a recombinant vector of this type, and to methods for the preparation of the said polypeptides. The homogeneous recombinant human interleukin-1 alpha polypeptides and pharmaceutical compositions which contain such polypeptides can be used to stimulate the immune system of a patient, to promote wound healing or to promote the recovery of seriously ill, protein-undernourished patients.
[EP0324447A2]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14445788A | 1988-01-15 | 1988-01-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
IE890087L true IE890087L (en) | 1989-07-15 |
Family
ID=22508674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE890087A IE890087L (en) | 1988-01-15 | 1989-01-13 | Recombinant human interleukin-1 alpha polypeptides |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0324447B1 (en) |
JP (1) | JP2567079B2 (en) |
AR (1) | AR245958A1 (en) |
AT (1) | ATE142696T1 (en) |
AU (1) | AU616461B2 (en) |
DE (1) | DE58909723D1 (en) |
DK (1) | DK16489A (en) |
ES (1) | ES2091752T3 (en) |
FI (1) | FI890175A (en) |
GR (1) | GR3021887T3 (en) |
HU (1) | HU208996B (en) |
IE (1) | IE890087L (en) |
IL (1) | IL88934A (en) |
MC (1) | MC2002A1 (en) |
NO (1) | NO890174L (en) |
NZ (1) | NZ227594A (en) |
PT (1) | PT89438B (en) |
YU (1) | YU6889A (en) |
ZA (1) | ZA89202B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0188920B1 (en) * | 1984-12-25 | 1993-09-29 | Dainippon Pharmaceutical Co., Ltd. | Interleukin 1 and its derivative |
DE3818660A1 (en) * | 1987-06-05 | 1988-12-15 | Colgate Palmolive Co | FREE-FLOWING, POWDERY DISHWASHING DETERGENT AND METHOD FOR PRODUCING THE SAME |
EP0644203A1 (en) * | 1988-07-29 | 1995-03-22 | Otsuka Pharmaceutical Co., Ltd. | IL-1alpha derivatives and medicament for treating thrombocytopenia |
US6191269B1 (en) * | 1997-05-30 | 2001-02-20 | The Regents Of The University Of California | Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
US7176179B1 (en) | 1997-05-30 | 2007-02-13 | The Regents Of The University Of California | Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
US20030154504A1 (en) | 1998-06-24 | 2003-08-14 | Farese Robert V. | Methods and compositions for modulating carbohydrate metabolism |
DE10252634A1 (en) * | 2002-11-11 | 2004-05-27 | Umwelttechnik Georg Fritzmeier Gmbh & Co. | Purification of sewage or other substances laden with harmful organic matter and detergent or clarifying agent also useful laundry and cleaning surfaces involve introduction of photosensitizer releasing singlet oxygen when stimulated |
BR112012007399A2 (en) * | 2009-09-29 | 2016-08-09 | United Technologies Ut Ag | oral care composition, uses of human recombinant interleukin-1 and methods for reducing bad breath and for the treatment or prevention of periodontal disease. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0188920B1 (en) * | 1984-12-25 | 1993-09-29 | Dainippon Pharmaceutical Co., Ltd. | Interleukin 1 and its derivative |
EP0200986B2 (en) * | 1985-04-25 | 1998-03-11 | F. Hoffmann-La Roche Ag | Recombinant human interleukin-1 |
DE3515217A1 (en) * | 1985-04-26 | 1986-10-30 | Siemens AG, 1000 Berlin und 8000 München | DEVICE FOR MEASURING LOW MAGNETIC FIELDS |
US5017692A (en) * | 1986-09-04 | 1991-05-21 | Schering Corporation | Truncated human interleukin-a alpha |
-
1989
- 1989-01-10 ZA ZA89202A patent/ZA89202B/en unknown
- 1989-01-11 DE DE58909723T patent/DE58909723D1/en not_active Expired - Fee Related
- 1989-01-11 ES ES89100402T patent/ES2091752T3/en not_active Expired - Lifetime
- 1989-01-11 HU HU8980A patent/HU208996B/en not_active IP Right Cessation
- 1989-01-11 EP EP89100402A patent/EP0324447B1/en not_active Expired - Lifetime
- 1989-01-11 NZ NZ227594A patent/NZ227594A/en unknown
- 1989-01-11 AT AT89100402T patent/ATE142696T1/en not_active IP Right Cessation
- 1989-01-12 IL IL8893489A patent/IL88934A/en not_active IP Right Cessation
- 1989-01-12 YU YU00068/89A patent/YU6889A/en unknown
- 1989-01-12 AR AR89312971A patent/AR245958A1/en active
- 1989-01-12 MC MC892025A patent/MC2002A1/en unknown
- 1989-01-13 AU AU28509/89A patent/AU616461B2/en not_active Ceased
- 1989-01-13 PT PT89438A patent/PT89438B/en not_active IP Right Cessation
- 1989-01-13 JP JP1005058A patent/JP2567079B2/en not_active Expired - Lifetime
- 1989-01-13 IE IE890087A patent/IE890087L/en unknown
- 1989-01-13 NO NO89890174A patent/NO890174L/en unknown
- 1989-01-13 DK DK016489A patent/DK16489A/en not_active Application Discontinuation
- 1989-01-13 FI FI890175A patent/FI890175A/en not_active IP Right Cessation
-
1996
- 1996-12-04 GR GR960403302T patent/GR3021887T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ227594A (en) | 1991-09-25 |
EP0324447B1 (en) | 1996-09-11 |
EP0324447A3 (en) | 1990-01-31 |
NO890174L (en) | 1989-07-17 |
JPH025892A (en) | 1990-01-10 |
GR3021887T3 (en) | 1997-03-31 |
IL88934A (en) | 1994-05-30 |
EP0324447A2 (en) | 1989-07-19 |
NO890174D0 (en) | 1989-01-13 |
DE58909723D1 (en) | 1996-10-17 |
IL88934A0 (en) | 1989-08-15 |
PT89438B (en) | 1993-09-30 |
ES2091752T3 (en) | 1996-11-16 |
PT89438A (en) | 1990-02-08 |
FI890175A0 (en) | 1989-01-13 |
YU6889A (en) | 1990-08-31 |
AU616461B2 (en) | 1991-10-31 |
AU2850989A (en) | 1989-07-20 |
JP2567079B2 (en) | 1996-12-25 |
AR245958A1 (en) | 1994-03-30 |
MC2002A1 (en) | 1990-01-26 |
DK16489D0 (en) | 1989-01-13 |
ZA89202B (en) | 1989-09-27 |
HU208996B (en) | 1994-09-28 |
DK16489A (en) | 1989-07-16 |
ATE142696T1 (en) | 1996-09-15 |
HUT50505A (en) | 1990-02-28 |
FI890175A (en) | 1989-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1026692A (en) | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same | |
EP0278776A3 (en) | Methods and deoxyribonucleic acid for the preparation of tissue factor protein | |
HUP9902429A2 (en) | Modulators of tnf receptor associated factor (traf), their preparation and use | |
EP0853121A3 (en) | Human DNase | |
WO1996034953A3 (en) | Cd16-ii variants | |
IL99401A0 (en) | Nucleotide sequence coding for an outer membrane protein and use of said protein in vaccine preparations | |
ZA943465B (en) | Transforming growth factor alpha H1 | |
GB9224584D0 (en) | Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases | |
AU6787894A (en) | Adenoviral vectors of animal origin and use in gene therapy | |
NO873699D0 (en) | POLYPEPTIDE SUITABLE FOR DIMENSION, TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASES SUCH AS ARTICLES. | |
IE871967L (en) | Binding-factor-related polypeptides | |
IL81221A0 (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them | |
IE890087L (en) | Recombinant human interleukin-1 alpha polypeptides | |
IL87391A0 (en) | Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them | |
IL90391A0 (en) | Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them | |
AU7440087A (en) | Process for isolating and purifying p. falciparum cs protein vaccine expressed in recombinant e. coli | |
ZA904565B (en) | Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection | |
IL86852A0 (en) | Homologues of human aprotinin,host strains and expression vectors for their preparation and pharmaceutical compositions containing them | |
IL112075A0 (en) | Recombinant human thymopoietin proteins, their preparation and their medicinal use | |
KR880700820A (en) | Vascular Factor (PAF) | |
WO1998035045A3 (en) | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | |
WO1998022580A3 (en) | Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation | |
WO2003014293A3 (en) | Novel polypeptide analogs and fusions and their methods of use | |
EP0315081A3 (en) | Anti-coagulating protein pp4-x, its preparation and use | |
BG101846A (en) | HUMAN DNase I VARIANTS |